Course Description
This web seminar will review the FDA’s February 2025 updates to its guidance for Institutional Review Boards (IRBs) and clinical investigators. Learners will explore the key revisions, new regulatory expectations, and practical implications for IRB oversight and investigator responsibilities in depth, and will gain a clear understanding of compliance requirements and best practices for implementing these changes in clinical research by the end of the course.
Learning Objectives
Who Should Attend
Instructor
Elizabeth Ronk Nelson, M.P.H.
Click here for complete trainer biographies
Registration Fees
$835*
*Includes up to 20 participants per login at a single location. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional logins for other locations, please call +1 781.972.5400 or toll-free in the U.S. 800.856.2556, or email customer.service@barnettinternational.com for pricing.
Accreditation Information
Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 2 hours (0.2 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will issue a receipt of completion for earned CEUs within three weeks of program completion. ACPE#: 0778-0000-25-052-L99-P. Released: 8/25.
Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.